Authentidate Holding Corp. Reports Fiscal 2013 Fourth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Authentidate Holding Corp. Reports Fiscal 2013 Fourth Quarter and Full-Year Results

BERKELEY HEIGHTS, N.J., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Authentidate Holding Corp. (Nasdaq: ADAT ), a provider of secure web-based software applications and telehealth products and services for healthcare organizations, today announced financial results for the three- and 12-month periods ended June 30, 2013.

Selected highlights for the fiscal year include:

  • Increased revenues and reduced operating losses for the quarter and fiscal year periods. For the year, revenues increased approximately 51% due to growth from both telehealth products and services and hosted software services.
  • Strengthened our balance sheet with the conversion of the company's outstanding shares of Series C convertible redeemable preferred stock to common stock, the cancellation of $6.5 million of senior secured notes in exchange for shares of Series D convertible preferred stock and warrants, and the completion of an underwritten public offering of the company's common stock and warrants for net proceeds of approximately $3.93 million.
  • Completed the required test-in phase with the Department of Veterans Affairs (VA) for our Electronic House Call (EHC) and Interactive Voice Response (IVR) telehealth solutions; the VA approved the use of these solutions by VA facilities throughout the country.
  • Completed the integration between the VA's VistA Electronic Health Records system and the company's telehealth solutions; the VA approved the use of the interface in its national telehealth program and also approved a number of new Disease Management Protocols (DMPs) for both telehealth solutions, significantly increasing the available patient population for these solutions.
  • Announced several new customers for our Inscrybe® Referral Management and Hospital Discharge solutions and a co-marketing agreement with Fastrack™ Healthcare Systems, a Mediware company, for an interface between the referral management solution and the Fastrack Enterprise practice management system.
  • Introduced a mobile telehealth tablet and a telehealth software application to address the growing need for mobility in the telehealth market, complement current products and services and provide for a broader range of price points and patient segments that can benefit from telehealth.

Following the end of the fiscal year, the company announced that it had started to enroll patients for its sole-source VA telehealth pilot program for Human Immunodeficiency Virus (HIV) patients. We also announced new customers for the telehealth and referral management solutions and the retention of Hayden IR as our new investor relations firm.

Ben Benjamin, Chief Executive Officer of Authentidate, stated, "The significant progress we made with our VA telehealth project during fiscal 2013 helped drive a meaningful increase in our revenues for the second half of the year. We continue to work closely with the VA and believe that the extension of our contract for the second of four option years reflects positive progress with this project. We are also encouraged by the growing number of VA locations using our products and services as well as the sole-source award from the VA for a telehealth pilot program for HIV patients. As we previously reported, the VA estimates that it provided care to more than 25,000 patients with HIV in 2011. Although we cannot predict the number of patients that will be enrolled in the program, we believe it represents an important opportunity and should help us accelerate our revenue growth in fiscal 2014 and beyond. Our fiscal 2013 accomplishments and a growing base of recurring revenues leave us enthusiastic about the next few quarters as well as the long term opportunities for our business."

Mr. Benjamin continued, "We continue to focus on growing sales of our telehealth products and services to the VA and commercial customers, increasing the use of our referral management services by our existing customers and expanding our presence in the hospital discharge market. We are pursuing a number of opportunities for our products and services with large healthcare organizations and hospital systems and believe our experience serving the VA, which is the largest integrated healthcare system and telehealth consumer in the country, our innovative products and services and our responsive customer service leave us well positioned for future growth and profitability. We are off to a great start in fiscal 2014 as companies such as ours, that offer leading products and services that cut healthcare costs and improve patient outcomes, are gaining increasing attention. We believe Authentidate has the right products and services for the emerging needs of healthcare organizations as the market develops and confronts ongoing regulatory reforms and industry trends affecting the healthcare industry."

Fourth Quarter Financial Results

Revenues for the quarter ended June 30, 2013 increased approximately 43% to $1.4 million compared to $1.0 million for the prior year period. These results primarily reflect an increase in revenues from telehealth products and services. Revenues for the fourth quarter increased approximately 2.5% compared to the third quarter of fiscal 2013 reflecting higher revenues from telehealth products and services and the timing of product shipments.

Operating loss for the quarter ended June 30, 2013 was $1.6 million compared to $2.2 million for the prior year period. This decrease reflects the increase in revenues and lower total operating expenses for the period resulting from our expense management measures implemented in January 2013. Net loss for the quarter was $3.4 million, or $0.12 per share, compared to $2.8 million, or $0.13 per share, for the prior year period. The increase in net loss for the quarter is due to the increase in the non-cash amortization of the debt discount on the company's senior secured notes of approximately $0.2 million and the non-cash loss of approximately $1.1 million on the early extinguishment of certain senior secured notes in exchange for Series D preferred stock and warrants which offset the lower operating loss for the current period.

Full-Year Financial Results

Revenues for the year ended June 30, 2013 increased approximately 51% to $4.8 million compared to $3.2 million for the prior year period. The increase in revenues for the period reflects an increase in revenues from both telehealth products and services and hosted software services.

Operating loss for the year ended June 30, 2013 was $7.4 million compared to $7.7 million for the prior year period. This decrease reflects the increase in revenues for the period which offset the increase in total operating expenses. Net loss for the year was $11.3 million, or $0.45 per share, compared to $8.4 million, or $0.35 per share, for the prior year period. The increase in net loss for the period is due to the increase in the non-cash amortization of the debt discount on the company's senior secured notes of approximately $2.3 million and the non-cash loss on early extinguishment of notes discussed above which offset the lower operating loss for the current year. The prior year period also reflects a payroll tax credit which lowered expenses for the period.

Balance Sheet

As of June 30, 2013 cash, cash equivalents and marketable securities were $3.7 million and the company had working capital of $4.9 million.

Mr. Benjamin concluded, "This was a strong end to an important year for Authentidate. We grew revenues 43% for the quarter and 51% for the year and reduced our operating losses for the periods, demonstrating the leverage we have in our business model. We strengthened our balance sheet with the equity transactions we completed in the fourth quarter of fiscal 2013 and we will continue to manage our operating expenses and cash needs as we move through fiscal 2014. We are excited about the opportunities ahead for Authentidate as our products and services gain further market acceptance and we expect our financial results to continue to improve."

Conference Call Details

Management will host a conference call on Thursday, September 26, 2013, at 4:30 p.m. ET, to discuss the latest corporate developments and results. The dial-in number for callers in the U.S. is (877) 407-8293 and the dial in number for international callers is (201) 689-8349.

A dial-in replay of the call will be available through October 3, 2013. To access the replay, please dial (877) 660-6853 in the U.S. and (201) 612-7415 internationally, and then enter the conference ID # 421155.

About Authentidate Holding Corp.

Authentidate Holding Corp. is a provider of secure web-based software applications and telehealth products and services that enable healthcare organizations to coordinate care for patients and enhance related administrative and clinical workflows. Authentidate's products and services enable healthcare organizations to increase revenues, reduce costs and enhance patient care by eliminating paper and manual work steps from clinical and administrative processes. Authentidate's telehealth solutions combine patient vital signs monitoring with a web application that streamlines patient care management. Delivered as Software as a Service (SaaS), customers only require an Internet connection and web browser to access our web-based applications thereby utilizing previous investments in systems and technology. The company's healthcare customers and users include leading homecare companies, health systems, physician groups and governmental entities. These organizations utilize the company's products and services to coordinate care for patients outside of acute-care.                       

For more information, visit the company's website at  www.authentidate.com .

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Act of 1934. When used in this release, the words "believe," "anticipate," "think," "intend," "plan," "will be," "expect," and similar expressions identify such forward-looking statements. Such statements regarding future events and/or the future financial performance of the company are subject to certain risks and uncertainties, which could cause actual events or the actual future results of the company to differ materially from any forward-looking statement. Such risks and uncertainties include, among other things, the availability of any needed financing, the company's ability to implement its business plan for various applications of its technologies, the impact of competition, the management of growth, and the other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking statements included herein, the inclusion of such statements should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved.

Authentidate and Inscrybe are registered trademarks of Authentidate Holding Corp. All other trade names are the property of their respective owners.

Authentidate Holding Corp. and Subsidiaries
Condensed Consolidated Balance Sheet Data
     
     
     
  June 30,
( in thousands, except per share data ) 2013 2012
     
Assets    
Current Assets    
Cash and cash equivalents  $ 3,505  $ 2,036
Restricted cash  256  256
Marketable securities  210  210
Accounts receivable, net   566  645
Inventory  3,959  4,016
Prepaid expenses and other current assets   688  1,286
Total current assets   9,184  8,449
Property and equipment, net   733  917
Other assets    
Software development costs, net   --  171
Licenses, net  2,082  2,196
Other assets  1,194  1,128
Total assets   $ 13,193  $ 12,861
     
Liabilities, Redeemable Preferred Stock and Shareholders' Equity    
Current liabilities    
Accounts payable, accrued expenses and other liabilities  $ 3,459  $ 3,547
Senior secured notes, net of unamortized discount  724  --
Deferred revenue  150  100
Total current liabilities   4,333  3,647
Senior secured notes, net of unamortized discount  --  2,866
Long-term deferred revenue  184  281
Total liabilities  4,517  6,794
Commitments and contingencies     
Redeemable preferred stock   --  3,254
Shareholders' equity     
Preferred stock, $.10 par value; 5,000 shares authorized, Series B, 28 shares and Series D, 665 shares issued and outstanding on June 30, 2013  69  --
Common stock, $.001 par value; 100,000 shares authorized, 35,339 and 26,999 issued and outstanding on June 30, 2013 and 2012, respectively   35  27
Additional paid-in capital   197,409  179,890
Accumulated deficit   (188,837)  (177,104)
Total shareholders' equity   8,676  2,813
Total liabilities, redeemable preferred stock and shareholders' equity   $ 13,193  $ 12,861
 
Authentidate Holding Corp. and Subsidiaries
Condensed Consolidated Statement of Operations and Comprehensive Operations Data
(Quarterly Information is Unaudited)
         
  Three Months Ended  Year Ended 
  June 30, June 30,
(in thousands, except per share data) 2013 2012 2013 2012
         
Revenues        
Hosted software services  $ 656  $ 669  $ 2,706  $ 2,590
Telehealth products and services  789  343  2,121  598
Total revenues  1,445  1,012  4,827  3,188
Operating expenses        
Cost of revenues  933  901  3,454  2,589
Selling, general and administrative  1,676  1,754  6,816  6,359
Product development  251  284  1,085  928
Depreciation and amortization  222  279  843  1,019
Total operating expenses  3,082  3,218  12,198  10,895
Operating loss  (1,637)  (2,206)  (7,371)  (7,707)
Other (expense) income, net  (1,794)  (549)  (3,978)  (645)
Net loss  $ (3,431)  $ (2,755)  $ (11,349)  $ (8,352)
Basic and diluted loss per common share  $ (0.12)  $ (0.13)  $ (0.45)  $ (0.35)
Comprehensive operations        
Net loss  $ (3,431)  $ (2,755)  $ (11,349)  $ (8,352)
Comprehensive loss  $ (3,431)  $ (2,755)  $ (11,349)  $ (8,352)

Media Contacts: Peter Seltzberg, Hayden IR, or (646) 415-8972 Brett Maas, Hayden IR, or (646) 536-7331 Source: Authentidate Holding Corp.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of $100 Investment in TD Synnex - A 20-Year Review

Updated Category News Views 201

Understanding the Value of Long-Term Investments Investing can often feel daunting, but the story of TD Synnex (NYSE: SNX) illustrates the powerful potential of long-term commitment. Over the last two decades, the company's stock has outperformed the broader market, delivering compelling returns to its investors. The Journey of TD Synnex Over the Past 20 Years During this...

Continue Reading
Growth of Nuclear Medicine Software Market Expected to Surge

Updated Category News Views 101

Emerging Trends in the Nuclear Medicine Software Market The nuclear medicine software market is poised for significant growth, projected to reach approximately US$1,491.55 million by 2030. This represents a compound annual growth rate (CAGR) of 9.0% from its current valuation. As healthcare continues to evolve, the demand for precise and early diagnostics is paramount,...

Continue Reading
Quanterix Corporation Faces Investigation Amid Investor Concerns

Updated Category News Views 400

Quanterix Corporation Faces Scrutiny from Rosic Law Firm In a recent development, Quanterix Corporation (NASDAQ: QTRX) has come under investigation by the Rosen Law Firm. This esteemed global investor rights law firm is exploring potential securities claims on behalf of the company's shareholders. The investigation arises from allegations of misleading business...

Continue Reading
Navigating Market Dynamics: Strategies for Today's Investors

Updated Category News Views 139

Understanding Market Strategies To excel in today's stock market, it's essential to have a keen understanding of various investment strategies. The current landscape suggests that savvy investors can find profitable opportunities even amid volatility. Taking Advantage of Hedges In light of recent sell-offs, a prudent strategy involves taking partial profits on hedges....

Continue Reading
Celebrate the Magic of Middle-earth: A Unique Reunion Tour

Updated Category News Views 246

FAN EXPO Celebrates 25 Years of The Lord of the Rings FAN EXPO HQ is thrilled to announce a special celebration marking the 25th anniversary of the iconic film, The Lord of the Rings. This memorable event, titled An Evening with the Hobbits: In Celebration of 25 Years, will take place in 11 cities across North America, starting in January. Key cast members Elijah Wood,...

Continue Reading